Delivery Order SPE2DB22D9239-SPE2DB25FDL84
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 29, 2025, for the supply of Adcetris 50 mg vials, an oncology medication. The contract carries a ceiling value of approximately $64,054 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 19, 2025. This award was funded by the Defense Logistics Agency's Medical Supply Chain division and includes...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $48,718.68 for 50 mg vials of Adcetris, an oncology treatment used in cancer therapy. The award, issued on September 16, 2025, with an ultimate completion date of October 14, 2025, carries no set-aside designation and represents a delivery order under the company's larger Indefinite Delivery Contract with the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $97,437.36 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Adcetris 50 mg vials. This firm fixed-price delivery order, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The delivery order...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $29,818.84 by the Defense Logistics Agency to provide 50 milligram vials of ADCETRIS under contract number 4563107240. The place of performance will be in Park Ridge, Illinois, with completion by December 18, 2023. DMS Pharmaceutical Group is a woman-owned small business that holds an indefinite delivery contract with the Defense Logistics Agency, worth up to $5 million through December 2025, to supply...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-seven thousand two hundred seventy-three dollars and fifty-five cents ($37,273.55) by the Defense Logistics Agency Troop Support Medical. This order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceutical items and medical products to military treatment facilities supported by the Defense Logistics Agency. Under this delivery order, DMS...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $14,909.42 by the Defense Logistics Agency to provide 50 milligram vials of ADCETRIS under contract number 4562646627. The delivery order was awarded on October 24, 2023 and is scheduled for completion by November 15, 2023. No set-aside designation was applied to this procurement. DMS Pharmaceutical Group will fulfill the order from its facility located in Park Ridge, Illinois. Additionally, DMS...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-seven thousand two hundred seventy-three dollars and fifty-five cents ($37,273.55) by the Defense Logistics Agency Troop Support Medical. This order was issued against the prime vendor's existing indefinite delivery contract to supply pharmaceutical items and medical products to military treatment facilities globally. Under this award, DMS Pharmaceutical Group will provide 50 mg vials of ADCETRIS,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $61,258.56 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of 50 mg vials of the pharmaceutical drug ADCETRIS, with a period of performance through December 27, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 50 mg vials of ADCETRIS. The contract has a potential value of $74,020.36 and a completion date of February 20, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of branded and generic pharmaceutical products and medical supplies to federal agencies,...
- The U.S. government's Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $15,314.66 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which does not have a set-aside designation, is for the delivery of ADCETRIS 50 MG VIALS to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDL84Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $8,119.78 by the Defense Logistics Agency (DLA) for the supply of 50 mg vials of Adcetris, an oncology medication. This delivery order, issued under firm fixed-price terms, is expected to be completed by October 7, 2025, with the award date of September 16, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal procurement market. Performance of this order will take place at the company's facility in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 through November 2026. This comprehensive IDC framework enables the DLA to procure a broad range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's established position as a key pharmaceutical supplier within the federal supply chain, combined with its extensive portfolio of branded and generic prescription drugs, biologics, and specialty medications, supports the agency's medical readiness requirements across military health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 9/16/25 |